<b>KD&A</b> Release: Meeting Medical Software Regulatory Requirements Post author:Sam Post published:July 20, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Viking Therapeutics Reports Fourth Quarter And Year-End 2016 Financial Results And Provides Corporate Update March 21, 2017 Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017 Abbott Introduces Heartmate 3 Left Ventricular Assist System – The Latest Milestone In Therapy For Advanced Heart Failure Patients August 27, 2017
Viking Therapeutics Reports Fourth Quarter And Year-End 2016 Financial Results And Provides Corporate Update March 21, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
Abbott Introduces Heartmate 3 Left Ventricular Assist System – The Latest Milestone In Therapy For Advanced Heart Failure Patients August 27, 2017